Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
SOC Telemed, the nation’s largest national provider of telemedicine technology to healthcare providers, has acquired behavioral health telemedicine company JSA Health.
Never has so much data been available—but those in medicine face the ongoing challenge of making the most of what’s available. A new report from Deloitte examined just how medical technology companies can improve outcomes, reduce costs and bolster efficiency.
Seattle, Boston, Atlanta, New York and Columbus, Ohio, are just a handful of cities seeing hospitals enter the real estate space in a community-based approach to healthcare, NPR reported.
A team of Australian researchers found those who consulted online resources had better interactions, because it led to more informed discussions while not undermining trust in diagnoses and treatment plans. Still, while the activity was generally considered positive, searches could increase patient anxiety.
BrainsWay recently received de novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for treating obsessive compulsive disorder (OCD) in adults.
As the debate around rising drug prices heightens, pharmacy benefit managers are taking on more scrutiny over copays that are sometimes higher than buying the drug out of pocket.
HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.
Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.
Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.
